Blueprint Medicines is a global biopharmaceutical company dedicated to creating life-changing medicines that address significant unmet medical needs, primarily in oncology and rare diseases. The company employs a precision medicine approach, utilizing advanced drug discovery techniques to develop therapies targeting the genetic drivers of diseases. With a commitment to alleviating human suffering, Blueprint Medicines has successfully brought treatments to market for conditions such as systemic mastocytosis and continues to expand its pipeline with innovative therapies in areas like mast cell diseases and solid tumors. Driven by core values of putting patients first, fostering trust, and maintaining a sense of urgency, Blueprint Medicines promotes a collaborative and results-oriented culture that encourages individual ownership and continuous learning among its employees. The organization embraces flexibility through its BlueFlex model, which balances in-person collaboration with remote work to enhance productivity and adaptability.